SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVene Inc. announced today that it has received Breakthrough Device Designation by the FDA for the company’s BlueLeaf ® Endovenous Valve Formation ...
If your maintenance staff find themselves overwhelmed, and if unexpected control valve failures are costing the plant money ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results